Logo image of PRPO

PRECIPIO INC (PRPO) Stock Fundamental Analysis

NASDAQ:PRPO - Nasdaq - US74019L6020 - Common Stock - Currency: USD

6.25  -0.48 (-7.13%)

Fundamental Rating

2

PRPO gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 105 industry peers in the Health Care Providers & Services industry. Both the profitability and financial health of PRPO have multiple concerns. While showing a medium growth rate, PRPO is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year PRPO has reported negative net income.
In the past year PRPO had a positive cash flow from operations.
In the past 5 years PRPO always reported negative net income.
PRPO had negative operating cash flow in 4 of the past 5 years.
PRPO Yearly Net Income VS EBIT VS OCF VS FCFPRPO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10M -20M -30M

1.2 Ratios

With a Return On Assets value of -25.24%, PRPO is not doing good in the industry: 80.95% of the companies in the same industry are doing better.
PRPO's Return On Equity of -35.47% is on the low side compared to the rest of the industry. PRPO is outperformed by 70.48% of its industry peers.
Industry RankSector Rank
ROA -25.24%
ROE -35.47%
ROIC N/A
ROA(3y)-38.11%
ROA(5y)-41.96%
ROE(3y)-50.29%
ROE(5y)-56.88%
ROIC(3y)N/A
ROIC(5y)N/A
PRPO Yearly ROA, ROE, ROICPRPO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 -200 400 -400 -600 -800

1.3 Margins

The Gross Margin of PRPO (40.79%) is better than 68.57% of its industry peers.
PRPO's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for PRPO so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 40.79%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y14.74%
GM growth 5Y42.15%
PRPO Yearly Profit, Operating, Gross MarginsPRPO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K -1.5K

More info and screens

2

2. Health

2.1 Basic Checks

PRPO does not have a ROIC to compare to the WACC, probably because it is not profitable.
PRPO has more shares outstanding than it did 1 year ago.
The number of shares outstanding for PRPO has been increased compared to 5 years ago.
PRPO has a worse debt/assets ratio than last year.
PRPO Yearly Shares OutstandingPRPO Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M
PRPO Yearly Total Debt VS Total AssetsPRPO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

2.2 Solvency

PRPO has an Altman-Z score of -6.99. This is a bad value and indicates that PRPO is not financially healthy and even has some risk of bankruptcy.
PRPO has a Altman-Z score of -6.99. This is amonst the worse of the industry: PRPO underperforms 89.52% of its industry peers.
The Debt to FCF ratio of PRPO is 3.92, which is a good value as it means it would take PRPO, 3.92 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 3.92, PRPO is in the better half of the industry, outperforming 71.43% of the companies in the same industry.
PRPO has a Debt/Equity ratio of 0.04. This is a healthy value indicating a solid balance between debt and equity.
With a decent Debt to Equity ratio value of 0.04, PRPO is doing good in the industry, outperforming 79.05% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF 3.92
Altman-Z -6.99
ROIC/WACCN/A
WACC9.1%
PRPO Yearly LT Debt VS Equity VS FCFPRPO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M

2.3 Liquidity

A Current Ratio of 0.81 indicates that PRPO may have some problems paying its short term obligations.
With a Current ratio value of 0.81, PRPO is not doing good in the industry: 85.71% of the companies in the same industry are doing better.
A Quick Ratio of 0.64 indicates that PRPO may have some problems paying its short term obligations.
With a Quick ratio value of 0.64, PRPO is not doing good in the industry: 81.90% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.81
Quick Ratio 0.64
PRPO Yearly Current Assets VS Current LiabilitesPRPO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

More info and screens

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 39.32% over the past year.
The Revenue has grown by 21.93% in the past year. This is a very strong growth!
The Revenue has been growing by 42.72% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)39.32%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-137.43%
Revenue 1Y (TTM)21.93%
Revenue growth 3Y27.94%
Revenue growth 5Y42.72%
Sales Q2Q%25.9%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
PRPO Yearly Revenue VS EstimatesPRPO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
PRPO Yearly EPS VS EstimatesPRPO Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2019 2020 2021 2022 2023 2024 0 -5K -10K -15K

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for PRPO. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
PRPO Price Earnings VS Forward Price EarningsPRPO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

PRPO's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 43.4
EV/EBITDA N/A
PRPO Per share dataPRPO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

PRPO does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

PRECIPIO INC

NASDAQ:PRPO (4/25/2025, 12:52:40 PM)

6.25

-0.48 (-7.13%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)03-31 2025-03-31/amc
Earnings (Next)05-12 2025-05-12
Inst Owners4.95%
Inst Owner Change0%
Ins Owners12.6%
Ins Owner Change1.93%
Market Cap9.38M
Analysts82.86
Price TargetN/A
Short Float %0.98%
Short Ratio0.87
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-31.63%
Min Revenue beat(2)-33.21%
Max Revenue beat(2)-30.04%
Revenue beat(4)0
Avg Revenue beat(4)-30.2%
Min Revenue beat(4)-33.21%
Max Revenue beat(4)-26.2%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.51
P/FCF 43.4
P/OCF 21.36
P/B 0.78
P/tB 41.67
EV/EBITDA N/A
EPS(TTM)-2.96
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.14
FCFY2.3%
OCF(TTM)0.29
OCFY4.68%
SpS12.35
BVpS8.06
TBVpS0.15
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -25.24%
ROE -35.47%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 40.79%
FCFM 1.17%
ROA(3y)-38.11%
ROA(5y)-41.96%
ROE(3y)-50.29%
ROE(5y)-56.88%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y14.74%
GM growth 5Y42.15%
F-Score5
Asset Turnover1.09
Health
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF 3.92
Debt/EBITDA N/A
Cap/Depr 17.21%
Cap/Sales 1.2%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.81
Quick Ratio 0.64
Altman-Z -6.99
F-Score5
WACC9.1%
ROIC/WACCN/A
Cap/Depr(3y)15.96%
Cap/Depr(5y)23.27%
Cap/Sales(3y)1.67%
Cap/Sales(5y)3.03%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)39.32%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-137.43%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)21.93%
Revenue growth 3Y27.94%
Revenue growth 5Y42.72%
Sales Q2Q%25.9%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y44.7%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y105.86%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y112.34%
OCF growth 3YN/A
OCF growth 5YN/A